Q1 2019 Holdings
Filed 2019-05-15 | 164 holdings | $184.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ishares Nasdaq BiotechnologyPut | COMM | 464287956 | $27.1K | 242,000 | 0.0% |
| Merus N.V. | COMM | N5749R100 | $29.0K | 1,961,039 | 0.0% |
| Audentes Therapeutics(BOLDEUR) | COMM | 05070R104 | $36.4K | 933,640 | 0.0% |
| Nucana Biomed Ltd | ADR | 67022C106 | $38.5K | 2,266,666 | 0.0% |
| Nucana Biomed Ltd | Ordinary Shares | GB00BYWYV | $40.8K | 2,400,000 | 0.0% |
| Spark Therapeutics | COMM | 84652J103 | $54.8K | 481,270 | 0.0% |
| Y-mAbs Therapeutics, Inc(YMABUSD) | COMM | 984241109 | $55.2K | 2,104,278 | 0.0% |
| ObsEva SA | COMM | H5861P103 | $60.7K | 4,749,623 | 0.0% |
| Natera(NTRA) | COMM | 632307104 | $63.9K | 3,100,560 | 0.0% |
| Principia Biopharma(PRNB) | COMM | 74257L108 | $69.3K | 2,038,208 | 0.0% |
| Amarin | ADR | 023111206 | $108.1K | 5,208,305 | 0.1% |
| Biomarin Pharmaceutical Inc(BMRN) | COMM | 09061G101 | $1.6M | 18,494 | 0.9% |
| Akebia Therapeutics Inc(AKBA) | COMM | 00972D105 | $4.2M | 516,761 | 2.3% |
| Alnylam Pharmaceuticals Inc(ALNY) | COMM | 02043Q107 | $10.0M | 106,616 | 5.4% |
| Aclaris Therapeutics(ACRS) | COMM | 00461U105 | $11.5M | 1,911,573 | 6.2% |
| Coherus BioSciences(CHRS) | COMM | 19249H103 | $39.1M | 2,868,221 | 21.2% |
| Ascendis Pharma A/S(ASND) | ADR | 04351P101 | $117.5M | 998,538 | 63.6% |